Advertisement
Screener

Dare Bioscience, Inc. (DARE) Scorecard

2.8 / 5 stars · 68/120 Roast Me

Dare Bioscience, Inc. (DARE) Scorecard

  • 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
  • 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
  • 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.
40 QUARTERS × 3 ROAST BATTLES
20/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q21/3 WinDARE / S&P
15.93% / 15.20% 		LoseDARE / S&P
DARE unavailable / 15.00% 		LoseDARE / S&P
-66.98% / 50.40%
2026-Q11/3 LoseDARE / S&P
-5.70% / -4.33% 		LoseDARE / S&P
DARE unavailable / 11.30% 		WinDARE / S&P
433.33% / 27.70%
2025-Q41/3 LoseDARE / S&P
-8.10% / 2.65% 		LoseDARE / S&P
DARE unavailable / 9.00% 		WinDARE / S&P
155.10% / 13.40%
2025-Q31/3 LoseDARE / S&P
-12.13% / 8.12% 		LoseDARE / S&P
DARE unavailable / 4.61% 		WinDARE / S&P
248.15% / 13.45%
2025-Q21/3 LoseDARE / S&P
-17.30% / 10.94% 		LoseDARE / S&P
DARE unavailable / 4.83% 		WinDARE / S&P
99.07% / 10.63%
2025-Q10/3 LoseDARE / S&P
-7.37% / -4.27% 		LoseDARE / S&P
-99.08% / 4.98% 		LoseDARE / S&P
-95.29% / 10.57%
2024-Q40/3 LoseDARE / S&P
-3.70% / 2.41% 		LoseDARE / S&P
-99.65% / 5.25% 		LoseDARE / S&P
-84.19% / 6.15%
2024-Q31/3 LoseDARE / S&P
-19.64% / 5.89% 		WinDARE / S&P
88.13% / 5.89% 		LoseDARE / S&P
-79.15% / 6.11%
2024-Q20/3 LoseDARE / S&P
-31.43% / 4.28% 		LoseDARE / S&P
DARE unavailable / 5.38% 		LoseDARE / S&P
-31.65% / 5.12%
2024-Q12/3 WinDARE / S&P
58.58% / 10.56% 		LoseDARE / S&P
-71.83% / 5.71% 		WinDARE / S&P
961.11% / 5.59%
2023-Q41/3 LoseDARE / S&P
-33.12% / 11.69% 		LoseDARE / S&P
DARE unavailable / 6.81% 		WinDARE / S&P
737.84% / 7.78%
2023-Q31/3 LoseDARE / S&P
-49.23% / -3.27% 		LoseDARE / S&P
DARE unavailable / 7.52% 		WinDARE / S&P
619.44% / -5.03%
2023-Q21/3 LoseDARE / S&P
-12.50% / 8.74% 		LoseDARE / S&P
DARE unavailable / 9.50% 		WinDARE / S&P
243.48% / -8.57%
2023-Q11/3 WinDARE / S&P
25.30% / 7.50% 		LoseDARE / S&P
DARE unavailable / 10.77% 		LoseDARE / S&P
-43.75% / -15.69%
2022-Q40/3 LoseDARE / S&P
-17.00% / 7.56% 		LoseDARE / S&P
DARE unavailable / 11.88% 		LoseDARE / S&P
-47.14% / -17.99%
2022-Q30/3 LoseDARE / S&P
-18.70% / -4.88% 		LoseDARE / S&P
DARE unavailable / 13.47% 		LoseDARE / S&P
-51.35% / -1.41%
2022-Q20/3 LoseDARE / S&P
-17.45% / -16.10% 		LoseDARE / S&P
DARE unavailable / 13.71% 		LoseDARE / S&P
-42.50% / 11.04%
2022-Q10/3 LoseDARE / S&P
-25.50% / -4.60% 		LoseDARE / S&P
DARE unavailable / 15.97% 		LoseDARE / S&P
-28.09% / 42.23%
2021-Q41/3 WinDARE / S&P
19.76% / 11.03% 		LoseDARE / S&P
DARE unavailable / 15.00% 		LoseDARE / S&P
DARE unavailable / 96.40%
2021-Q30/3 LoseDARE / S&P
-11.64% / 0.58% 		LoseDARE / S&P
DARE unavailable / 10.77% 		LoseDARE / S&P
DARE unavailable / 69.42%
2021-Q21/3 WinDARE / S&P
11.83% / 8.55% 		LoseDARE / S&P
DARE unavailable / 6.58% 		LoseDARE / S&P
DARE unavailable / 51.81%
2021-Q11/3 WinDARE / S&P
26.12% / 6.17% 		LoseDARE / S&P
DARE unavailable / -1.06% 		LoseDARE / S&P
DARE unavailable / 7.39%
2020-Q41/3 WinDARE / S&P
34.13% / 12.15% 		LoseDARE / S&P
DARE unavailable / -3.72% 		LoseDARE / S&P
DARE unavailable / -33.42%
2020-Q30/3 LoseDARE / S&P
1.01% / 8.93% 		LoseDARE / S&P
DARE unavailable / -2.04% 		LoseDARE / S&P
DARE unavailable / -27.10%
2020-Q20/3 LoseDARE / S&P
16.35% / 20.54% 		LoseDARE / S&P
DARE unavailable / -0.46% 		LoseDARE / S&P
DARE unavailable / -27.11%
2020-Q11/3 WinDARE / S&P
3.66% / -19.60% 		LoseDARE / S&P
DARE unavailable / 3.47% 		LoseDARE / S&P
DARE unavailable / -14.75%
2019-Q40/3 LoseDARE / S&P
5.13% / 9.07% 		LoseDARE / S&P
DARE unavailable / 5.36% 		LoseDARE / S&P
DARE unavailable / 2.99%
2019-Q30/3 LoseDARE / S&P
-8.24% / 1.70% 		LoseDARE / S&P
DARE unavailable / 5.02% 		LoseDARE / S&P
DARE unavailable / 0.21%
2019-Q20/3 LoseDARE / S&P
-39.29% / 4.30% 		LoseDARE / S&P
DARE unavailable / 6.64% 		LoseDARE / S&P
DARE unavailable / 8.65%
2019-Q11/3 WinDARE / S&P
96.91% / 13.65% 		LoseDARE / S&P
DARE unavailable / 8.12% 		LoseDARE / S&P
DARE unavailable / 14.29%
2018-Q40/3 LoseDARE / S&P
-27.08% / -13.52% 		LoseDARE / S&P
DARE unavailable / 9.05% 		LoseDARE / S&P
DARE unavailable / 18.23%
2018-Q30/3 LoseDARE / S&P
-16.67% / 7.71% 		LoseDARE / S&P
DARE unavailable / 10.21% 		LoseDARE / S&P
DARE unavailable / 19.06%
2018-Q21/3 WinDARE / S&P
39.62% / 3.43% 		LoseDARE / S&P
DARE unavailable / 9.03% 		LoseDARE / S&P
DARE unavailable / 14.46%
2018-Q10/3 LoseDARE / S&P
-61.28% / -0.76% 		LoseDARE / S&P
DARE unavailable / 7.68% 		LoseDARE / S&P
DARE unavailable / 12.46%
2017-Q40/3 LoseDARE / S&P
-30.64% / 6.64% 		LoseDARE / S&P
DARE unavailable / 7.03% 		LoseDARE / S&P
DARE unavailable / 13.82%
2017-Q30/3 LoseDARE / S&P
-29.73% / 4.48% 		LoseDARE / S&P
DARE unavailable / 5.68% 		LoseDARE / S&P
DARE unavailable / 17.57%
2017-Q20/3 LoseDARE / S&P
-45.32% / 3.09% 		LoseDARE / S&P
DARE unavailable / 4.83% 		LoseDARE / S&P
DARE unavailable / 17.74%
2017-Q11/3 WinDARE / S&P
14.69% / 6.07% 		LoseDARE / S&P
DARE unavailable / 3.67% 		LoseDARE / S&P
DARE unavailable / 13.32%
2016-Q40/3 LoseDARE / S&P
-32.38% / 3.82% 		LoseDARE / S&P
DARE unavailable / 2.09% 		LoseDARE / S&P
DARE unavailable / 7.05%
2016-Q30/3 LoseDARE / S&P
-50.61% / 3.85% 		LoseDARE / S&P
DARE unavailable / 0.20% 		LoseDARE / S&P
DARE unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

MetricDARE total returnS&P 500 Total Return Index
Total return-63.42%20.78%
Annualized return-63.42%20.78%

5Y · 2021-09-01 to 2026-08-27

MetricDARE total returnS&P 500 Total Return Index
Total return-96.48%83.14%
Annualized return-48.80%12.86%

10Y · 2016-09-01 to 2026-08-27

MetricDARE total returnS&P 500 Total Return Index
Total return-99.40%319.30%
Annualized return-40.01%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock NameCountryMarket CapPE Ratio
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Moleculin Biotech, Inc. (MBRX)United States$0.011B
MetaVia Inc. (MTVA)United States$0.011B-0.65
KALA BIO, Inc. (KALA)United States$0.011B-3.33
BIOVIE INC. (BIVI)United States$0.012B
Theriva Biologics, Inc. (TOVX)United States$0.011B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
Advertisement